Page 1860 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

71. McNamara RM, Aaron CK, Gemborys M, et al. Sorbitol and therapeutic considerations. Clin Pharmacokinet. 1993;
catharsis does not enhance efficacy of charcoal in a simulated 24:362-379.
acetaminophen overdose. Ann Emerg Med. 1988;17:243-246. 92. Golper TA. Drug removal during continuous hemofiltration or
72. Barceloux D, McGuigan M, Hartigan-Go K. Position statement: hemodialysis. Contrib Nephrol. 1991;93:110-116.
cathartics. American Academy of Clinical Toxicology; European 93. Bellomo R, Kearly Y, Parkin G, et al. Treatment of life-
Association of Poisons Centres and Clinical Toxicologists. threatening lithium toxicity with continuous arterio-venous
J Toxicol Clin Toxicol. 1997;35:743-752. hemodiafiltration. Crit Care Med. 1991;19:836-837.
73. Position paper: whole bowel irrigation. J Toxicol Clin Toxicol. 94. Leblanc M, Raymond M, Bonnardeaux A, et al. Lithium
2004;42:843-854. poisoning treated by high-performance continuous arterio-
74. Goldfrank LR, Flomenbaum N. Goldfrank’s Toxicologic Emergencies. venous and venovenous hemodiafiltration. Am J Kidney Dis.
8th ed. New York: McGraw-Hill, Medical Pub Division; 2006. 1996;27:365-372.
75. Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine 95. Collee GG, Hanson GC. The management of acute poisoning.
alkalinization. J Toxicol Clin Toxicol. 2004;42:1-26. Br J Anaesth. 1993;70:562-573.
76. Ismail N, Becker BN. Common poisoning and drug overdose. 96. Brett AS, Rothschild N, Gray R, et al. Predicting the clinical
In: Jacobson HR, Striker JE, Klahr S, eds. The Principles and course in intentional drug overdose. Implications for use of the
Practice of Nephrology. 2nd ed. St Louis, MO: Mosby; 1995:726. intensive care unit. Arch Intern Med. 1987;147:133-137.
77. Winchester JF: Active methods for detoxification. In: Haddad 97. Kulling P, Persson H. Role of the intensive care unit in the man-
LM, Winchester JF, eds. Clinical Management of Poisoning and agement of the poisoned patient. Med Toxicol. 1986;1:375-386.
Drug Overdose. 2nd ed. Philadelphia, PA: Saunders; 1990:174. 98. Manini AF, Hoffman RS. On the Use of Glasgow Coma Scale
78. Garella S. Extracorporeal techniques in the treatment of exog- as a Predictor of ICU Admission in Deliberate Drug Poisoning.
enous intoxications. Kidney Int. 1988;33:735-754. Basic Clin Pharmacol Toxicol. 2013; doi: 10.1111/bcpt.12187
79. Pond SM. Diuresis, dialysis, and hemoperfusion: indications (Epub ahead of print).
and benefits. Emerg Med Clin North Am. 1984;2:29-45. 99. Callaham M. Admission criteria for tricyclic antidepressant
80. Pond SM. Extracorporeal techniques in the treatment of ingestion. West J Med. 1982;137:425-429.
poisoned patients. Med J Aust. 1991;154:617-622. 100. Linden CH, Rumack BH. Acetaminophen overdose. Emerg Med
81. Winchester JF. Use of dialysis and hemoperfusion in treatment Clin North Am. 1984;2:103-119.
of poisoning. In: Daugirdas JT, Ing TS, eds. Handbook of 101. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years.
Dialysis. 2nd ed. Boston, MA: Little, Brown; 1994:569. J Toxicol Clin Toxicol. 2002;40:3-20.
82. Gwilt PR, Perrier D. Plasma protein binding and distribution 102. Rumack BH, Matthew H. Acetaminophen poisoning and toxic-
characteristics of drugs as indices of their hemodialyzability. ity. Pediatrics. 1975;55:871-876.
Clin Pharmacol Ther. 1978;24:154-161. 103. Whitcomb DC, Block GD. Association of acetaminophen
83. Blye E, Lorch J, Cortell S. Extracorporeal therapy in the hepatotoxicity with fasting and ethanol use. JAMA. 1994;272:
treatment of intoxication. Am J Kidney Dis. 1984;3:321-338. 1845-1850.
84. Tilstone WJ, Winchester JF, Reavey PC. The use of pharmaco- 104. Bond GR, Hite LK. Population-based incidence and outcome
kinetic principles in determining the effectiveness of removal of of acetaminophen poisoning by type of ingestion. Acad Emerg
toxins from blood. Clin Pharmacokinet. 1979;4:23-37. Med. 1999;6:1115-1120.
85. Alexander DP, Gambertoglio JG: Drug overdose and pharma- 105. Buckley NA, Whyte IM, O'Connell DL, et al. Activated char-
cologic considerations in dialysis. In: Cogan MG, Garovoy MR, coal reduces the need for N-acetylcysteine treatment after
eds. Introduction to Dialysis. New York: Churchill Livingston; acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol.
1985:261. 1999;37:753-757.
86. Aronoff GR, Brier ME. Prescribing drugs for dialysis patients. 106. Holubek WJ, Hoffman RS, Goldfarb DS, et al. Use of hemo-
In: Henrich WL, ed. Principles and Practice of Dialysis. 3rd ed. dialysis and hemoperfusion in poisoned patients. Kidney Int.
Philadelphia, PA: Lippincott Williams & Wilkins; 2004:147. 2008;74:1327-1334.
87. DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination 107. Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis.
during high-flux hemodialysis: kinetic model and comparison 2007;11:525-548, vi.
of four membranes. Am J Kidney Dis. 1992;20:354-360. 108. Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral
88. Touchette MA, Patel RV, Anandan JV, et al. Vancomycin N-acetylcysteine in the treatment of acetaminophen overdose.
removal by high-flux polysulfone hemodialysis membranes in Analysis of the national multicenter study (1976 to 1985).
critically ill patients with end-stage renal disease. Am J Kidney N Engl J Med. 1988;319:1557-1562.
Dis. 1995;26:469-474. 109. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetyl-
89. Winchester JF, Kriger FL. Hemoperfusion. In: Jacobson HR, cysteine in paracetamol induced fulminant hepatic failure: a
Striker JE, Klahr S, eds. The Principles and Practice of Nephrology. prospective controlled trial. BMJ. 1991;303:1026-1029.
2nd ed. St Louis, MO: Mosby; 1995:721. 110. Harrison PM, Keays R, Bray GP, et al. Improved outcome of
90. Golper TA, Wedel SK, Kaplan AA, et al. Drug removal during paracetamol-induced fulminant hepatic failure by late adminis-
continuous arteriovenous hemofiltration: theory and clinical tration of acetylcysteine. Lancet. 1990;335:1572-1573.
observations. Int J Artif Organs. 1985;8:307-312. 111. Harrison PM, Wendon JA, Gimson AE, et al. Improvement by
91. Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients acetylcysteine of hemodynamics and oxygen transport in fulmi-
during continuous renal replacement therapy. Pharmacokinetic nant hepatic failure. N Engl J Med. 1991;324:1852-1857.

Section11-O-Ref.indd 3 12/10/2014 8:08:24 PM